This article describes a new, combined, quantitative method for assessing excipient risks that has been developed by the authors as one possible risk evaluation method.
Olena Ruban
Advertisement
Articles by Olena Ruban
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Thermo Fisher's Kane Says AI Is Reshaping How CDMOs Add Value
2
MilliporeSigma's Arana Maps the Gaps Holding Back CGT Manufacturing
3
FDA Approves Pfizer’s Breast Cancer Treatment
4
Q&A: Why Pharma Deal Volume Is Down but Value Is Up
5